Nephrology PhD, MD, and MPhil Supervisors

Dr Jonathan Barratt

  • Genetics and epigenetics of IgA Nephropathy
  • Role of the innate immune system in IgA Nephropathy
  • Novel therapies in IgA Nephropathy
  • IgA structure and function
  • Lymphocyte trafficking and IgA Nephropathy
  • Role of complement in glomerular injury in IgA Nephropathy

Dr Alan Bevington

  • Metabolic basis of catabolic states, in particular the stimulation of protein wasting in skeletal muscle in response to metabolic acidosis

Professor Nigel Brunskill

  • Cellular Mechanisms and novel interventions in proteinuric progressive renal disease and diabetic nephropathy
  • Complement pathways in tubulointerstitial disease
  • Study of microparticles as novel biomarkers of cardiovascular disease in uraemia
  • Community studies of chronic kidney disease and acute kidney injury risk factors, and implementation of novel management strategies

Dr James Burton

  • Mechanisms of left ventricular hypertrophy, inflammation and fibrosis in CKD
  • Interventions to improve cardiovascular outcomes in dialysis patients
  • Novel biomarkers for the assessment of cardiovascular risk in patients with CKD

Dr Emma Watson -

  • Therapeutic use of exercise in CKD
  • Molecular mechanisms of muscle wasting in human CKD

Share this page: